Pomdoctor Financials - Benzinga

Pomdoctor Ltd

POMNASDAQ

Trade with Public

Trade with Public

$0.9510

0.0212.26%

Últ. Act.: Aug 26, 8:38 AM

Panorámica general Noticias Previsión de beneficiosFinanzasSentimiento Comparar Informe de acciones

Pomdoctor Financials

Pomdoctor (POM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Pomdoctor FY EPS $(3.14), Sales $57.187M

Pomdoctor (NASDAQ:POM) reported quarterly losses of $(3.14) per share. The company reported $57.187 million in sales this quarter.

Benzinga Newsdesk

Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results

Avi Kapoor

US Stocks Mixed Ahead Of Fed Decision; Dow Surges 100 Points

Avi Kapoor

PRO
Pomdoctor H1 EPS $(1.60), Sales $24.400M

Pomdoctor (NASDAQ:POM) reported quarterly losses of $(1.60) per share. The company reported $24.400 million in sales this quarter.

Benzinga Newsdesk

PolyMet Q2 EPS ($0.01) vs ($0.01) est, No Revenue

Benzinga

Mid-Afternoon Market Update: American Public Education Rises Following Q4 Results; PTC Therapeutics Shares Fall

Benzinga

© 2026 Benzinga | All Rights Reserved